Structural drivers behind the current boom The East Africa pharma market sits inside a significant regional demand pool for packaged medicines across the continent. Kenya, Uganda and Tanzania are significant contributors to this demand, driven by expanding middle-class consumption and government commitments to universal health coverage. The broader Middle East & Africa (MEA) pharma market showed significant growth, reinforcing the momentum. East Africa mirrors this trend, with a supply gap that local manufacturers have not yet filled, especially for branded and specialty products. How the import-driven model shapes pricing and margins Because most of the market is supplied by foreign manufacturers, pricing follows global reference prices plus freight and customs duties. The cost structure leaves a margin for distributors after accounting for warehousing and cold-chain handling. That margin can be squeezed when a product enters without a proven demand signal because retailers demand price concessions. Entry strategies that work now 1. **Partner with a registered local distributor** who already holds Kenya Medical Supplies Authority (KEMSA) or Tanzania's Medical Stores Department (MSD) approvals. Their existing import licences cut clearance time. 2. **Focus on generic formulations of high-volume drugs** such as antihypertensives, antidiabetics and antibiotics. Generic prices can be lower than branded equivalents, giving you pricing wiggle room. 3. **Use the regional harmonised tariff** under the East African Community (EAC) Customs Union. Once a product clears customs in Kenya, you can move it tariff-free to Uganda and Rwanda, cutting cross-border costs. Risks to watch this quarter Customs inspections have tightened after a recent spike in counterfeit incidents reported by the Kenya Revenue Authority. Missing a required Kenya Bureau of Standards (KEBS) certificate for active ingredient purity can delay clearance and result in a fine. Supply-chain congestion at Mombasa Port adds hidden cost. Shippers who lock in berth slots early or use the new dry-port facility at Lamu can avoid the bottleneck. What other sectors can learn from pharma's model Agri-inputs firms face a similar import-heavy landscape; securing a local seed certification body speeds clearance. FMCG exporters to Kenya benefit from the same EAC tariff union, while machinery sellers must navigate higher import duties and stricter technical certifications. Energy equipment providers can replicate pharma's distributor-first approach by aligning with regional utilities that already handle import licences for solar panels and battery storage units. The Bottom Line East Africa's pharma market is growing. The fastest way to tap that growth this quarter is to sign a distribution agreement with a KEMSA-approved partner, target high-volume generic drugs, and use the EAC customs union to ship across borders without additional duties. Get a market intelligence report tailored to your product and target market.